Lerociclib Plus Fulvestrant in Patients with HR+/HER2− Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy: LEONARDA-1 a Phase III Randomized Trial
Nature Communications(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要